Krebs Biochemicals & Industries Limited

NSE KREBSBIO.NS

Krebs Biochemicals & Industries Limited EBIT for the year ending March 31, 2024: USD -1.80 M

Krebs Biochemicals & Industries Limited EBIT is USD -1.80 M for the year ending March 31, 2024, a 31.77% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Krebs Biochemicals & Industries Limited EBIT for the year ending March 31, 2023 was USD -2.64 M, a 48.73% change year over year.
  • Krebs Biochemicals & Industries Limited EBIT for the year ending March 31, 2022 was USD -5.15 M, a -70.93% change year over year.
  • Krebs Biochemicals & Industries Limited EBIT for the year ending March 31, 2021 was USD -3.02 M, a 0.96% change year over year.
  • Krebs Biochemicals & Industries Limited EBIT for the year ending March 31, 2020 was USD -3.04 M, a -53.62% change year over year.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
Loading...
SV Wall Street
NSE: KREBSBIO.NS

Krebs Biochemicals & Industries Limited

CEO Mr. Jitendra Rameshchandra Shah
IPO Date Oct. 27, 2016
Location India
Headquarters Maas Heights
Employees 191
Sector Healthcare
Industries
Description

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.

Similar companies

KOPRAN.NS

Kopran Limited

USD 2.08

-3.10%

KILITCH.NS

Kilitch Drugs (India) Limited

USD 3.72

1.96%

MANGALAM.NS

Mangalam Drugs & Organics Limited

USD 1.29

1.61%

INDSWFTLAB.NS

Ind-Swift Laboratories Limited

USD 1.17

-2.09%

JAGSNPHARM.NS

Jagsonpal Pharmaceuticals Limited

USD 3.04

-2.74%

StockViz Staff

February 8, 2025

Any question? Send us an email